The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,020.00
Bid: 1,955.00
Ask: 2,040.00
Change: 70.00 (3.59%)
Spread: 85.00 (4.348%)
Open: 2,050.00
High: 2,050.00
Low: 1,955.00
Prev. Close: 1,950.00
SUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement and Notice of Results

11 Feb 2021 07:00

RNS Number : 6787O
S & U PLC
11 February 2021
 

 

11 February 2021

 

S&U plc

("S&U" or "the Group")

 

TRADING STATEMENT AND NOTICE OF RESULTS

 

S&U plc, the specialist motor finance and property bridging lender, today issues a trading update for the period from its trading statement of 9 December 2020 to the Group's year end on 31 January 2021. The Group's full year results will be announced on 30 March 2021.

 

The Group's trading remains robust and profitable, despite the current lockdown and the induced coma into which the Government has needed to place the wider UK economy. Demand by customers in both divisions remains strong and collections quality continues to be good.

 

We are planning for a significant rebound to pre-Covid motor finance transaction levels as lockdown restrictions ease this year, and a substantial increase in business at Aspen our property bridging business.

 

Motor Finance

Transaction numbers at Advantage have held up well over the period and, despite the closure of a number of car showrooms, continue to improve. In the past 2 months new deal transactions have reached nearly 80% of the comparable period last year and rising. Record application numbers continue, although Advantage's prudently responsible underwriting and affordability requirements have seen new deal transactions for the year as a whole total around 15,600 with customer numbers at year end of just under 63,000 and net receivables of around £247m.

 

Advantage's industry leading customer analysis and an evolving product range present tremendous opportunity for growth throughout the non-prime finance spectrum, despite the more competitive environment.

 

Repayment quality remains good; Advantage's collections department has always been proud of the sustainable relationships it develops with customers. Thus, the number of customers remaining on payment holiday has reduced from 15,000 at the peak to below 4,000. These relationships are also reflected in their payment performance, and in January monthly collections improved to 90% of contractual terms due.

 

More important, despite an increase in covid cases in the first half of the period under review Advantage is keeping staff safe. Moreover, our continuous drive for improvement has seen the launch of initiatives on affiliate introducers, product development and customer service - the latter reflected in Advantage's latest Trustpilot consumer ratings of 4.8 out of 5.0.

 

Aspen Bridging

Aspen continues to make great progress both in terms of growth and quality. In a resilient residential housing market, (Zoopla's UK house price index recently reported year on year growth of 5.9%), Aspen has seen net receivables rise from £29.6m to around £34m in the period. During this time, new transactions have consistently beaten budget, and Aspen's deal pipeline has more than doubled.

 

Experience, market credibility and sensible underwriting have seen credit quality at its best ever, with only three of over sixty customers slightly beyond term at year end. These promising trends have justified a further £4m investment in Aspen over the past two months, and the recruitment of experienced new staff in business development and underwriting.

 

Funding

S&U's financial position has been strengthened still further as borrowings have fallen to £99m from £103m. Gearing now stands at approximately 55% from 58%. This reflects continued and seasonal cash generation at Advantage, offset by additional investment in Aspen. £130m of Group facilities provide significant headroom for growth.

 

Dividend

Despite the inevitable effect of Covid-19 on S&U's profitability, our confidence in future trading, our financial strength and consistent commitment to shareholder reward justify a second interim dividend this year of 25p per ordinary share (2020: 36p). This will be paid on 12th March 2021 to those shareholders on the register on the 20th February 2021.

 

 

Commenting on the Group's performance and outlook, Anthony Coombs, S&U Chairman, said:

 

"Although the return to economic and general health in the UK will be uneven, the outlook is undoubtedly brightening. The proven strength and experience of S&U, exemplified by our loyal and dedicated staff, make me confident that we can grasp the tremendous opportunities economic revival will bring."

 

 

For further information, please contact:

 

S&U

Anthony Coombs, Chairman 0121 705 7777

 

SEC Newgate 

Bob Huxford, Megan Kovach, Tom Carnegie 020 7653 9848

 

Peel Hunt

Adrian Trimmings, Andrew Buchanan, Rishi Shah 020 7418 8900

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAKAEFLFFEFA
Date   Source Headline
3rd May 20245:49 pmRNSDirector/PDMR and PCA Shareholding
3rd May 20242:00 pmRNSAnnual Report and Accounts
1st May 20244:19 pmRNSDirector/PDMR and PCA Shareholding
9th Apr 20247:00 amRNSPreliminary Unaudited FY Results to 31 Jan 24
25th Mar 20247:00 amRNSResults Presentations for Analysts and Investors
9th Feb 20247:00 amRNSTrading Statement and Notice of Results
1st Feb 20242:30 pmRNSNotice of Trading Update
11th Jan 20242:00 pmRNSDirector/PDMR Shareholding
12th Dec 20237:00 amRNSTrading Statement to 11 December 2023
31st Oct 20232:29 pmRNSDirector/PDMR and PCA Shareholding
5th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20237:00 amRNSInterim Results for the 6 months to 31 July 2023
4th Sep 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSTrading Update and Notice of Results
25th Jul 202311:34 amRNSDirector/PDMR Shareholding
17th Jul 20233:34 pmRNSDirector/PDMR Shareholding
26th May 20234:38 pmRNSDirector/PDMR Shareholding
25th May 202312:43 pmRNSResult of AGM
25th May 20237:00 amRNSAGM Statement and Trading Update
25th Apr 20232:00 pmRNSAnnual Report and Accounts
25th Apr 202311:48 amRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSMello Investor Presentation
6th Apr 20234:08 pmRNSAnnouncement of Annual Report and Accounts
28th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Mar 20237:00 amRNSPreliminary Results
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSResults Presentations for Analysts and Investors
14th Feb 20232:00 pmRNSAppointment of Executive Director
9th Feb 20237:00 amRNSTrading Statement and Notice of Results
8th Dec 20227:00 amRNSTrading Statement
27th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSResults Presentations for Analysts and Investors
18th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20227:00 amRNSTrading Update and Notice of Results
3rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
8th Jul 20225:06 pmRNSDirector/PDMR and PCA Shareholding
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 202212:33 pmRNSResult of AGM
26th May 20227:00 amRNSAGM Statement and Trading Update
23rd May 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
18th May 202211:30 amRNSOptions, Director/PDMR Shareholding, Voting Rights
13th May 20224:33 pmRNSDirector/PDMR Shareholding
5th May 20221:53 pmRNSDirector/PDMR Shareholding, Options, Voting Rights
26th Apr 20222:00 pmRNSAnnual Report and Accounts
4th Apr 20227:00 amEQSEdison Investment Research Limited: S&U (SUS): Seeing recovery and adapting to grow
4th Apr 20227:00 amRNSAnnual Report and Accounts
29th Mar 20227:00 amRNSPreliminary Results
9th Mar 20227:00 amRNSResults Presentations for Analysts and Investors
10th Feb 20227:00 amRNSTrading Statement and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.